Valproate-induced hyperammonemic encephalopathy: the role of clinical pharmacists in medication safety—a case report
Abstract Background Sodium valproate, a commonly prescribed antiepileptic drug in clinical practice, has been occasionally linked to hyperammonemia, although the precise mechanisms underlying this adverse effect remain poorly understood. This article reports a case of hyperammonemic encephalopathy i...
Saved in:
| Main Authors: | Wei Chen, Dong Wang, Wei Fu, Jinpeng Wang, Min Chen, Jun Li, Fei Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Medical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13256-025-05294-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01) -
Valproate Metabolites and Hyperammonemia
by: J Gordon Millichap
Published: (1992-07-01) -
What drives hyperammonemic encephalopathy in AED users: monotherapy risks or polypharmacy perils?
by: Qing Shan, et al.
Published: (2025-06-01) -
A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector
by: Nicole Keuler, et al.
Published: (2022-06-01) -
Case report and literature review of refractory hypoalbuminemic ascites caused by so-dium valproate
by: Hui-Min YANG, et al.
Published: (2021-10-01)